| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.4 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |